pubmed-article:16480348 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16480348 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
pubmed-article:16480348 | lifeskim:mentions | umls-concept:C0473161 | lld:lifeskim |
pubmed-article:16480348 | lifeskim:mentions | umls-concept:C0009378 | lld:lifeskim |
pubmed-article:16480348 | lifeskim:mentions | umls-concept:C0033487 | lld:lifeskim |
pubmed-article:16480348 | lifeskim:mentions | umls-concept:C0600097 | lld:lifeskim |
pubmed-article:16480348 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:16480348 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
pubmed-article:16480348 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
pubmed-article:16480348 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:16480348 | pubmed:dateCreated | 2006-2-16 | lld:pubmed |
pubmed-article:16480348 | pubmed:abstractText | Patient-controlled sedation (PCS) allows patients to match their sedation requirement to perceived discomfort. The significant delay in onset of sedation may be overcome with effect-site steered target controlled infusion, but previously only trials in volunteers have been carried out. We therefore conducted a randomised, double-blind controlled trial comparing effect-site steered propofol PCS with anaesthetist-administered propofol sedation in 40 patients presenting for colonoscopy. The initial effect-site target in the PCS group was 0.8 microg.ml(-1), increment was 0.1 microg.ml(-1) and lockout was 3 min. Patient and endoscopist satisfaction and operating conditions were similar between the two groups. PCS patients were sedated more slowly (13 [7.1] vs. 3 [1.1] min; p < 0.0001) and less deeply (minimum BIS value: 71 [16] vs. 58 [15]; p = 0.13) than anaesthetist-administered propofol sedation patients. More of the latter patients were hypotensive, but all patients had similar recollection of events during the procedure and similar quality of recovery. | lld:pubmed |
pubmed-article:16480348 | pubmed:language | eng | lld:pubmed |
pubmed-article:16480348 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16480348 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:16480348 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16480348 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16480348 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16480348 | pubmed:month | Mar | lld:pubmed |
pubmed-article:16480348 | pubmed:issn | 0003-2409 | lld:pubmed |
pubmed-article:16480348 | pubmed:author | pubmed-author:LeslieKK | lld:pubmed |
pubmed-article:16480348 | pubmed:author | pubmed-author:AbsalomA RAR | lld:pubmed |
pubmed-article:16480348 | pubmed:author | pubmed-author:StonellC ACA | lld:pubmed |
pubmed-article:16480348 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16480348 | pubmed:volume | 61 | lld:pubmed |
pubmed-article:16480348 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16480348 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16480348 | pubmed:pagination | 240-7 | lld:pubmed |
pubmed-article:16480348 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:meshHeading | pubmed-meshheading:16480348... | lld:pubmed |
pubmed-article:16480348 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16480348 | pubmed:articleTitle | Effect-site targeted patient-controlled sedation with propofol: comparison with anaesthetist administration for colonoscopy. | lld:pubmed |
pubmed-article:16480348 | pubmed:affiliation | Research Fellow, 2 Head of Research, Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Australia. | lld:pubmed |
pubmed-article:16480348 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16480348 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:16480348 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16480348 | lld:pubmed |